Prasugrel Monotherapy After PCI for Chronic Coronary Syndromes: The ASET Pilot Study
The ASET Pilot study showed that prasugrel monotherapy after PCI is safe and feasible in patients with chronic coronary syndromes treated with platinum-chromium everolimus-eluting stents (EES), despite differences in patient background, procedural characteristics, and prasugrel dose in Brazil and Japan, Dr. Shinichiro Masuda, University of Galway, Ireland, and colleagues reported in the online edition of JACC: ASIA.
- Free Registration
-
Already have an account?Log In
A portal site of complex catheter intervention techniques
TCROSS NEWS Global is an online medical journal that provides
valuable information on Cardiovascular medicine to medical professionals
worldwide.
We bring you the latest findings and trends in all areas of
cardiovascular medicine. Please register and subscribe for unlimited access to
quality Cardiovascular News!
We provide timely and up-to-date information to our partners across the world by covering and reporting live sessions and conferences, featuring of complex cases, newsletters, academic researches and case studies.
Recommendations
